Skip to main content
. Author manuscript; available in PMC: 2021 Apr 9.
Published in final edited form as: J Alzheimers Dis. 2020;77(3):1195–1207. doi: 10.3233/JAD-200190

Table 1A.

Comparisons across 3 classes in CN

Variables No NPS Depressed/Anxious (Dep/Anx) Agitated/Irritable (Agit/Irr) Comparison
Class Probability 0.808 0.137 0.054
Age 74.07 (6.60) 71.53 (6.60) 73.75 (6.91) No NPS > Dep/Anxb
Female 53.3% 54.0% 24.4% No NPS > Agit/Irra
Dep/Anx > Agit/Irrb
Education 16.31 (2.71) 15.92 (2.55) 16.51 (2.20) ns
ApoE4 positive 31.0% 41.9% 46.7% No NPS < Dep/Anxc
No NPS < Agit/Irrc
Cognitive Measures
MMSE 28.87 (1.30) 28.57 (1.43) 28.02 (1.50) No NPS > Agit/Irrb
AVLT Long Delay 7.75 (3.80) 7.85 (3.65) 5.89 (3.93) No NPS > Agit/Irra
Dep/Anx > Agit/Irrc
AVLT Recognition* 13.12 (2.17) 13.53 (2.14) 12.87 (1.69) ns
Trails A 34.70 (11.87) 37.92 (14.32) 42.00 (14.97) No NPS < Agit/Irrb
Trails B 85.41 (39.07) 93.82 (43.42) 93.71 (27.93) ns
Animals 20.50 (5.44) 19.84 (4.95) 19.22 (5.03) ns
BNT 27.97 (2.06) 28.07 (1.76) 27.49 (1.88) ns
CSF AD Biomarker Profile
Aβ positive 37.3% 36.2% 48.6% ns
p-tau positive 39.3% 48.3% 45.7% ns
t-tau positive 38.9% 46.6% 48.6% ns
Aβ × p-tau positive 17.1% 24.1% 22.9% ns
CSF AD Biomarker Measurements
1301.80 (637.48) 1232.45 (507.28) 1247.69 (649.91) ns
p-tau 22.14 (9.90) 25.05 (13.27) 23.12 (11.64) ns
t-tau 240.24 (95.77) 261.63 (113.86) 245.23 (107.48) ns

Notes.

Analyses were based on the most likely class membership assignment. Means and standard deviations are provided for age, years of education, neuropsychological measures, and AD CSF biomarker measurements. Proportions are provided for sex, ApoE4 carrier status, and CSF AD biomarker profiles.

*

Overall ANOVA model was significant; however, post-hoc analyses revealed no significant differences between classes.

Post-hoc analyses:

a

Difference between the two classes is significant at p<.001;

b

Difference between the two classes is significant at p<.01;

c

Difference between the two classes is significant at p<.05.

CN = cognitively normal; ApoE4 = apolipoprotein E-ε4; MMSE = Mini-Mental State Examination; AVLT = Rey Auditory Verbal Learning Test; Trails A = Trail Making Test A; Trails B = Trail Making Test B; BNT = Boston Naming Test; CSF = cerebrospinal fluid; AD = Alzheimer’s disease; Aβ = amyloid beta; p-tau = phosphorylated tau; t-tau = total tau; ns = not significant